The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

The Florida Attorney General’s Office says the settlement will help fund opioid addiction treatment, prevention and recovery programs.

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half of what was originally anticipated before a Supreme Court decision put settlement funds in limbo last year.

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid crisis, according to the office of Massachusetts Attorney General Andrea Joy Campbell.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription painkiller.

Connecticut and 14 other states on Thursday agreed to a new settlement deal with the Sackler family and Purdue Pharma that would secure $7.4 billion for communities across the United States that have been impacted by the opioid crisis.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction crisis in the U.

Members of the family who own OxyContin maker Purdue Pharma and the company itself agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller,